Multiple Myeloma Research Foundation - MMRF - Genomics
Patient Symposium - MCRT Webcast Myeloma Crowd Round Table, 05/08/2021, Dana-Farber Cancer Institute
NCT04939844: Phase 2: REST - Replacing Steroids in the Transplant Ineligble (REST)
NCT04843579: Phase 2: Selinexor in Combination With Clarithromycin, Pom & Dex RRMM - ClaSPd
NCT04802356: Phase 2: Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma
Multiple Myeloma Research Foundation - MMRF - Clinical Trials
What is the MMRF CureCloud®? Welcome to the MMRF CureCloud! Multiple Myeloma Research Foundation
American Cancer Society - www.cancer.org: What is CART Cell Therapy?
NCT04935580: Phase 1/2: Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients
Patient Symposium - MCRT Webcast Myeloma Crowd Round Table, 04/24/2021
THE MMRF - Multiple Myeloma Autologous Stem Cell Transplantation
Multiple Myeloma Research Foundation - MMRF -Autologous Hematopoietic Stem Cell Transplantation ASCT
NCT04879043: Phase 1/2: Study to Assess Safety of HDP-101 in Patients With RRMM
Roswell Park - What is a Clinical Trial? Clearing Up Common Misconceptions
Expanded Access Protocol for Receiving Idecabtagene Vicleucel That is Nonconforming for commercial
NCT04891809: Phase 2 - Isatuximab in Combination With Rd Compared to Rd in Elderly NDMM
What are Multiple myeloma defining events? International Myeloma Working Group - SLiM-CRAB Criteria
NCT04835129: Phase 2: Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in RRMM (IMPEDE)
NCT04824794: Phase 1/2: GEN3014 Safety Trial in Relapsed or Refractory Hematologic Malignancies
NCT04754945: Phase 1: Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
NCT04786028: Phase 2 - A Study of Isatuximab Added to Standard CyBorD Induction & Lenalidomide Maint
NCT04776395: Phase 2: Iberdomide Alone or in Combination With Dex for Intermediate/High-Risk SMM
THE MMRF - The Path to Precision Medicine in Multiple Myeloma
KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in RRMM